日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity.

Src 家族激酶抑制剂药物达沙替尼和糖皮质激素对舌鳞状细胞癌具有协同作用,并能降低 MET 激酶活性

Hmedat Ali N A, Doondeea Jessica, Ebner Daniel, Feller Stephan M, Lewitzky Marc

Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay

致癌基因Gata1导致巨核细胞分化阶段特异性延迟

Juban, Gaëtan; Sakakini, Nathalie; Chagraoui, Hedia; Cruz Hernandez, David; Cheng, Qian; Soady, Kelly; Stoilova, Bilyana; Garnett, Catherine; Waithe, Dominic; Otto, Georg; Doondeea, Jessica; Usukhbayar, Batchimeg; Karkoulia, Elena; Alexiou, Maria; Strouboulis, John; Morrissey, Edward; Roberts, Irene; Porcher, Catherine; Vyas, Paresh